Because GLP-1 signaling affects how quickly food leaves the stomach, many of the earliest side effects are gastrointestinal
Written by: Gaurav Kaushik, Ph.D., SVP & Head of AI, Veradigm, and Cheryl Reifsnyder, PhD Initially approved for diabetes management, GLP-1 agonists (GLP-1s) are now widely used for weight loss and have also demonstrated potential in several other therapeutic areas
Retrieved from Ding, C., Lim, L
Your doctor will typically: Check blood tests (potassium, kidney function) before starting and periodically during treatment Monitor your blood pressure regularly Adjust either medications dose based on your response and any side effects Possibly increase monitoring frequency if you have heart failure, kidney disease, or take other medications affecting potassium Take home message Mounjaro and spironolactone can be taken together safely, but this combination requires appropriate monitoring of potassium levels, kidney function, and blood pressure